CRISPR companies calling for article retraction from Nature Methods – If the same or similar sequence of letters appears elsewhere in the genome, that can result in an unintentional or off-target edit – Concerns of Harm caused by Gene Editing using CRISPR-Cas9 Reporter: Aviva Lev-Ari, PhD, RN Storm around the call for “Nature Methods […]
Search Results for 'CRISPR'
CRISPR companies calling for article retraction from Nature Methods – If the same or similar sequence of letters appears elsewhere in the genome, that can result in an unintentional or off-target edit – Concerns of Harm caused by Gene Editing using CRISPR-Cas9
Posted in CRISPR/Cas9 & Gene Editing on November 12, 2019| 2 Comments »
CRISPR Cuts Turn Gels into Biological Watchdogs
Posted in CRISPR/Cas9 & Gene Editing, tagged Cas12a, CRISPR, CRISPR-based gene editing, human genome, hydrogel on August 30, 2019| Leave a Comment »
Update 6/11/2020 CRISPR-IL used to develop next-gen genome editing products Haifa-based Pluristem Therapeutics is a regenerative medicine company that plans to develop next-generation multi-species genome editing products for human, plant and animal DNA that could improve work done in the pharma, agriculture and aquaculture industries. The CRISPR-IL consortium includes Sheba Medical Center and Schneider Children’s Medical […]
On July 19, 2019, Merck KGaA-owned Sigma-Aldrich has petitioned the US Patent and Trademark Office (USPTO) to open an interference proceeding between its own pending CRISPR-Cas9 patents and patents awarded to the University of California, Berkeley (UC Berkeley).
Posted in Uncategorized on July 23, 2019| Leave a Comment »
Merck KGaA-owned Sigma-Aldrich has petitioned the US Patent and Trademark Office (USPTO) to open an interference proceeding between its own pending CRISPR-Cas9 patents and patents awarded to the University of California, Berkeley (UC Berkeley). On Friday, July 19, Sigma-Aldrich submitted the request, available on blog PatentDocs, asking for a parallel interference to the one declared by the […]
At Technical University of Munich (TUM) Successful Genetical modification of a patient’s own immune cells, T cell receptors, using CRISPR-Cas9 gene editing tool. The engineered T cells are very similar to the physiological immune cells.
Posted in CRISPR/Cas9 & Gene Editing on July 17, 2019| Leave a Comment »
At Technical University of Munich (TUM) Successful Genetical modification of a patient’s own immune cells, T cell receptors, using CRISPR-Cas9 gene editing tool. The engineered T cells are very similar to the physiological immune cells. Reporter: Aviva Lev-Ari, PhD, RN Targeted exchange using the CRISPR-Cas9 gene scissors The problem with conventional methods is that the […]
FIVE Forthcoming Books on CRISPR in 2019-2020: Flooded market or CRISPR-fatigued readers – Not to Worry !!!!!
Posted in CRISPR/Cas9 & Gene Editing on July 4, 2019| Leave a Comment »
FIVE Forthcoming Books on CRISPR in 2019-2020: Flooded market or CRISPR-fatigued readers – Not to Worry !!!!! Author: Aviva Lev-Ari, PhD, RN From: Aviva Lev-Ari <AvivaLev-Ari@alum.berkeley.edu> Date: Thursday, July 4, 2019 at 8:39 PM To: <damian.garde@statnews.com> Cc: Marcus W Feldman <mfeldman@stanford.edu>, “Stephen Williams, PhD” <sjwilliamspa@comcast.net>, Aviva Lev-Ari <AvivaLev-Ari@alum.berkeley.edu>, Gail Thornton <gailsthornton@yahoo.com> Subject: Regarding your […]
Optimization of CRISPR Gene Editing with Gold Nanoparticles
Posted in CRISPR/Cas9 & Gene Editing, tagged CRISPR-based gene editing, DNA repair, genetic engineering, RNA, stem cells on June 13, 2019| Leave a Comment »
Optimization of CRISPR Gene Editing with Gold Nanoparticles Reporter: Irina Robu, PhD The CRISPR-Cas9 gene editing system has been welcomed as a hopeful solution to a range of genetic diseases, but the expertise has proven hard to deliver into cells. One plan is to open the cell membrane using an electric shock, but that can […]
Breakthrough in Gene Editing CRISPR–Cas systems: First example of a fully programmable, RNA-guided integrase and lays the foundation for genomic manipulations that obviate the requirements for double-strand breaks and homology-directed repair.
Posted in CRISPR alternative for editing genes without cutting, CRISPR/Cas9 & Gene Editing, Transposon-encoded CRISPR–Cas systems direct RNA-guided DNA integration on June 13, 2019| Leave a Comment »
Breakthrough in Gene Editing CRISPR–Cas systems: First example of a fully programmable, RNA-guided integrase and lays the foundation for genomic manipulations that obviate the requirements for double-strand breaks and homology-directed repair. Reporter: Aviva Lev-Ari, PhD, RN CRISPR alternatives for editing genes without cutting: CRISPR 12, 12a, 13, 14 – Alternative Techniques to CRISPR/Cas9 […]
Laboratory for Genomics Research (LGR) to be established by GSK ($67M investment in 5 years) at UC, Berkeley/UCSF to be lead by Prof. Jennifer Doudna focusing on immunology, oncology, and neuroscience disease-causing gene mutations and development of new technologies using CRISPR to accelerate new drug discovery
Posted in BioTechnology - Venture Creation, CRISPR/Cas9 & Gene Editing on June 13, 2019| 1 Comment »
Laboratory for Genomics Research (LGR) to be established by GSK ($67M investment in 5 years) at UC, Berkeley/UCSF to be lead by Prof. Jennifer Doudna focusing on immunology, oncology, and neuroscience disease-causing gene mutations and development of new technologies using CRISPR to accelerate new drug discovery Reporter: Aviva Lev-Ari, PhD, RN GlaxoSmithKline, UC’s […]
Alternative to CRISPR/Cas9 – CAST (CRISPR-associated transposase) – A New Gene-editing Approach for insertion of Large DNA Sequences into a Genome developed @BroadInstitute @MIT @Harvard
Posted in CAST - Alternative to CRISPR/Cas9, CRISPR/Cas9 & Gene Editing on June 11, 2019| Leave a Comment »
Alternative to CRISPR/Cas9 – CAST (CRISPR-associated transposase) – A New Gene-editing Approach for Insertion of Large DNA Sequences into a Genome developed @BroadInstitute @MIT @Harvard Reporter: Aviva Lev-Ari, PhD, RN A new gene-editing CAST member In Science, a team led by Jonathan Strecker, Alim Ladha, and core institute member Feng Zhang reports a new gene-editing approach that […]
Top 10 CRISPR Podcasts Every Scientist (& Non-Scientist) by Synthego.com
Posted in CRISPR/Cas9 & Gene Editing, LPBI Group, e-Scientific Media, DFP, R&D-M3DP, R&D-Drug Discovery, US Patents: SOPs and Team Management on March 9, 2019| Leave a Comment »
Top 10 CRISPR Podcasts Every Scientist (& Non-Scientist) by Synthego.com Reporter: Aviva Lev-Ari, PhD, RN On 3/12/2015 – Dr. Williams posted Podcast Review: Quiet Innovation Podcast on Obtaining $ for Your Startup Reporter: Stephen J. Williams, Ph.D. https://pharmaceuticalintelligence.com/2015/03/12/podcast-review-quiet-innovation-podcast-on-obtaining-for-your-startup/ On 1/25/2016 – I posted Launching LPBI’s, Fourth Line of Business (D): FIVE Podcast – Audio […]
